Through this acquisition, CONMED acquires next-generation bioinductive collagen scaffold technology for application in sports medicine soft tissue healing.
The action is intended to support increased efficiency in the outpatient ambulatory surgery center market for doctors who treat degenerative spine disease.
The entities seek to develop new decision support tools, powered by data collection and machine learning, to provide data-driven recommendations to surgeons for robotic-assisted joint surgery.
Orthofix Medical commenced limited market release and first patient implant of the Virtuosâ„¢ Lyograft, a reportedly first-of-its-kind, shelf-stable and complete...